ACRF Department of Cancer Biology and Therapeutics and Division of Genome Sciences and Cancer, John Curtin School of Medical Research, Australian National University, Acton, Canberra, Australia.
Curr Protoc. 2023 Nov;3(11):e921. doi: 10.1002/cpz1.921.
Mouse embryonic fibroblasts (MEFs) are primary fibroblasts purified from mouse embryos at a defined time post-fertilization. MEFs have versatile applications, including use as feeder cell layers or sources of untransformed primary cells for a variety of biological assays. MEFs are most commonly isolated between embryonic day (E)12.5 and E13.5 but can be isolated from embryos as early as E8.5 and as late as E15.5. The individual embryos are harvested by carefully removing uterine tissue, yolk sac, and placenta. The embryos are euthanized, and non-mesenchymal tissues, such as the fetal liver and heart, are removed before tissue homogenization. The remaining fetal tissue is homogenized by mechanical mincing using a sterile blade, followed by enzymatic digestion and resuspension. During tissue dissociation, the duration of trypsin-EDTA/DNase digestion and enzyme concentration are critical parameters to produce high-quality MEFs with the highest rates of cell viability and proliferation potential. MEFs can be cryopreserved at passage (P) 0 if >80% confluent, passaged for further expansion before freezing down, or directly utilized for downstream applications, i.e., preparation as feeder cell layers. Primary MEFs possess a limited proliferation capacity of ∼20 cell divisions, beyond which the percentage of senescent cells rapidly increases; thus, cultures should only be expanded/passaged to a maximum of P5. Critical for cell viability during cryopreservation and thawing of MEFs is the slow decrease in temperature when freezing, the rapid increase when thawing, the use of a cryoprotective agent, and an optimal cell density. While it is critical to generate high-quality MEFs to standardize and optimize preparation procedures and utilize fresh reagents, some variability in proliferation capacity and cell viability between MEF preparations remains. Thus, MEF preparation, culture, and cryopreservation procedures are continuously being optimized. © 2023 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol: Purification, passaging, and expansion of MEFs Supporting Protocol: Cryopreservation and thawing of MEFs.
小鼠胚胎成纤维细胞(MEFs)是从受精后特定时间的胚胎中纯化得到的原代成纤维细胞。MEFs 具有广泛的应用,包括用作饲养细胞层或未转化的原代细胞的来源,用于各种生物学测定。MEFs 通常在胚胎第 12.5 天(E)到第 13.5 天之间分离,但也可以从第 8.5 天的胚胎中分离,甚至可以从第 15.5 天的胚胎中分离。通过小心地去除子宫组织、卵黄囊和胎盘来收获单个胚胎。胚胎被安乐死,在组织匀浆之前去除非间充质组织,如胎肝和胎心。然后使用无菌刀片进行机械切碎来匀浆剩余的胎儿组织,接着进行酶消化和悬浮。在组织解离过程中,胰蛋白酶-EDTA/DNase 消化的时间和酶浓度是关键参数,它们可以产生具有最高细胞活力和增殖潜力的高质量 MEFs。如果细胞达到 80%以上汇合度,可以在传代 0 时冷冻保存 MEFs,在传代前进一步扩增,然后再冷冻,或者直接用于下游应用,例如制备饲养细胞层。原代 MEFs 的增殖能力有限,约为 20 次细胞分裂,超过这个次数,衰老细胞的比例迅速增加;因此,培养物的扩增/传代不应超过 P5。在 MEFs 的冷冻保存和解冻过程中,关键是在冷冻过程中缓慢降温,在解冻过程中快速升温,使用冷冻保护剂和优化的细胞密度。虽然生成高质量的 MEFs 以标准化和优化制备程序并使用新鲜试剂非常重要,但 MEF 制剂之间的增殖能力和细胞活力仍存在一些差异。因此,MEF 的制备、培养和冷冻保存程序正在不断优化。© 2023 作者。Wiley 期刊出版的《当代协议》。基本方案:MEFs 的纯化、传代和扩增支持方案:MEFs 的冷冻保存和解冻。